Limited Competition Brain Disorders in the Developing World Research Across the Lifespan (R01)) | Apply Online

Frequently Asked Questions (FAQs)

What is the "Limited Competition Brain Disorders in the Developing World Research Across the Lifespan (R01)" opportunity (PAR-11-030)?

PAR-11-030 is an NIH discretionary grant opportunity that used the R01 mechanism to support collaborative, innovative research focused on nervous system function and neurological or neuropsychiatric disorders across the entire human lifespan. A central requirement is clear relevance to low- and middle-income countries (LMICs), with projects designed to address LMIC public health needs and realities.

What is the main goal of this funding opportunity?

The main goal is to fund research partnerships that produce meaningful scientific findings while also strengthening research capacity in LMICs. The program emphasizes projects that improve understanding of how nervous system conditions develop and affect people across different life stages, and how that knowledge can be translated into better diagnostics, treatments, and prevention strategies tailored to LMIC settings.

What does "across the lifespan" mean in this announcement?

"Across the lifespan" signals NIH interest in the full arc of nervous system development and impairment, including early development, childhood and adolescent conditions, adult-onset disorders, and aging-related neurological decline. Projects can focus on one life stage or multiple stages, as long as the LMIC public health significance is strong and clearly justified.

What types of health conditions and topics are within scope?

The scope includes nervous system function as well as neurological and neuropsychiatric disorders. The FOA is intentionally cross-cutting and aligns with multiple NIH research areas (including mental health, alcohol research, drug abuse and addiction, neurosciences and neurological disorders, child health and human development, aging, environmental health, and international research and research training). The key is that the proposed science and the training/capacity-building elements fit the FOA purpose and LMIC relevance is compelling.

Is this a research-only grant, or does it require training components?

This opportunity has a dual focus on research and research training. Applications are expected to include meaningful collaboration between investigators from high-income countries (HICs) and LMICs, with LMIC partners positioned to gain skills, infrastructure, and sustainable institutional capability. The intent is not only to publish results, but to leave behind stronger local capacity to continue addressing brain and nervous system disorders after the grant period ends.

What is the expected partnership model between high-income countries and LMICs?

NIH is looking for true research partnerships between HIC and LMIC investigators. The collaboration is expected to combine scientific discovery with hands-on research training, and to support long-term strengthening of LMIC research ecosystems so local investigators and institutions can increasingly identify priorities, run high-quality studies, and contribute to global leadership in neurology and mental health-related fields.

What grant mechanism does this opportunity use?

The announcement uses the NIH R01 mechanism, which supports investigator-initiated research projects of substantial scope under the standard NIH research project grant structure. It is described as a discretionary funding program and uses a grant funding instrument.

Who is the sponsoring agency?

The sponsoring agency is the National Institutes of Health (NIH). The full announcement was hosted through the NIH grants guide.

Which organizations are eligible to apply?

Eligibility is broad and includes many U.S. and non-U.S. organization types. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including 501(c)(3) and certain nonprofits without 501(c)(3) status), for-profit organizations (including small businesses and other for-profit entities), and multiple government entity types.

Are non-U.S. (foreign) organizations eligible?

Yes. The eligibility language explicitly includes non-domestic (non-U.S.) entities (foreign organizations), as well as regional organizations, and U.S. territories or possessions.

What government entities are eligible applicants?

Eligible government entities include state governments, county governments, city or township governments, special district governments, and independent school districts. The opportunity also lists eligible federal agencies.

Are tribal and minority-serving institutions included in eligibility?

Yes. The eligibility list explicitly includes tribal and minority-serving institutions, including historically black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, and related categories.

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are explicitly included among eligible applicants.

Is cost sharing or matching required?

No. The opportunity states there is no cost sharing or matching requirement, which can reduce barriers for applicants, including those working in resource-constrained settings.

Is this funding opportunity still open?

No. The FOA was created and posted on November 12, 2010, had an original closing date of April 11, 2013, and was archived on May 12, 2013. Those dates indicate the specific announcement is no longer active.

Why might this archived FOA still matter to applicants or institutions today?

Even though it is archived, the description can still be useful as a model for NIH global brain and nervous system research initiatives that prioritize equitable collaboration between HIC and LMIC investigators and emphasize long-term research capacity building in LMIC institutions.

What kinds of outcomes does NIH appear to value in this program?

Based on the description, NIH values outcomes that include strong scientific discovery and publishable findings, plus practical translation of knowledge into improved diagnostics, treatments, and prevention strategies suited to LMIC contexts. A defining valued outcome is sustainable strengthening of LMIC research capability, including skills, infrastructure, and institutional capacity that persist beyond the grant period.

How does the FOA describe the importance of LMIC relevance?

LMIC relevance is described as a clear emphasis and a core requirement. Projects are expected to address nervous system conditions as they occur in LMIC populations and settings, and to demonstrate strong public health significance for those communities.

What CFDA areas are associated with this opportunity?

The FOA is tied to multiple CFDA listings spanning environmental health, mental health research, alcohol research, drug abuse and addiction research, neurosciences and neurological disorders, child health and human development, aging research, and international research and research training. This reflects the program's cross-cutting nature across NIH areas.

Where was the full announcement hosted, and who was listed for technical help?

The full announcement was hosted through the NIH grants guide. For technical issues accessing the announcement or link problems, the listed contact route was the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.